Drug Type Fusion protein |
Synonyms OGB-21501 |
Mechanism FGF21R agonists, GCGR agonists(Glucagon receptor agonists), GIPR agonists(Gastric inhibitory polypeptide receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization Onegene BiotechnologyStartup |
Active Organization Onegene BiotechnologyStartup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Discovery | KR | Onegene BiotechnologyStartup | 30 Jan 2022 |
Nonalcoholic Steatohepatitis | Discovery | KR | Onegene BiotechnologyStartup | - |
Obesity | Discovery | KR | Onegene BiotechnologyStartup | - |